|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
Industry efforts to ensure the supply of effective medicines – whether it be tougher measures to combat counterfeits, better cold chain standards, or quality management priorities – are explored in this edition's PMPS. Industry Advisor Robert Harris provides an introduction.
|
|
|
|
|
Temperature-Controlled Packaging
Up to Standard?
The move to large molecule medicines calls for greater reassurance of temperature-controlled packaging reliability. Richard Wood of Peli BioThermal calls for a new industry-wide standard performance measure to help bring speed and simplicity to supply across challenging shipping routes.
|
|
|
Packaging TCO
At All Cost
CSafe Global's Brian Kohr argues for a total cost of ownership approach to steer temperature-controlled packaging decisions. The entire supply chain process – from packaging engineering and operations through to logistics, quality and end-use – should be assessed and wider stakeholder input sought.
|
|
|
|
|
Nasal Drug Delivery
Nosing Around
Gerallt Williams from Aptar Pharma describes how the benefits of unit and bi-dose nasal and sub-lingual spray devices – notably, their wide therapeutic range and ability to improve safety and adherence – make them well-placed to tackle the problems currently surfacing within the drug delivery space.
|
|
|
Auto-Injection Devices
Patients Come First
Jochen Ratjen of SHL Group identifies the key considerations for device designers of self-administered injections. While human factors engineering is a central preoccupation and source of inspiration, creative ideas must not neglect manufacturing feasibility.
|
|
|
Pre-Filled Syringes
Case in Point
Pre-filled syringes contain various properties and performance requirements needed for appropriate functionality. In light of recent research and regulations, William Dierick and Hideaki Kiminami from Terumo explore changing priorities and device developments.
|
|
|
|
|
Product Blinding
Behind the Mask
As rules and regulations for clinical studies pile up for packaging manufacturers, Frank Jäger at Faubel explores how, through innovative blinding and labelling techniques, guidelines can be met head on for the greater benefit of consumers, CROs and pharma companies.
|
|
|
|
|
Spotlight
Tightly Sealed
Vial-based parenterals are closed with a rubber stopper before being crimped with an aluminium cap. Datwyler Sealing Solutions outlines the flip caps that are an essential feature, which
are shaped through separate manufacturing processes before being mechanically assembled to make one product.
|
|
|
Tablet Tooling
Formulating a Fix
Rob Blanchard of I Holland reviews the physical variables that cause problems for tablet pressing. While persistent tooling issues do arise, a thorough review of tablet features, factoring in formulation, can go a long way to ensuring the production of robust products on a grand scale.
|
|
|
|
Serialisation Legislation
Challenging Counterfeits
Incoming serialisation requirements will no doubt place big compliance burdens on the industry, but in the longer term will replace forgery with transparency – and open the
door to genuinely personalised medicine. Gaurav Banerjee, Rick Seibert and Jonathan Laverick at Sharp Packaging Solutions report.
|
|
|
|
Event Review
Flying Start
Reflecting on the success of the inaugural FlyPharma Conference, co-organised by PMPS, Alan Kennedy at PartnerSave Ltd highlights the key take-home messages from September’s event, which probed the need for highly responsive, increasingly cohesive supply chains.
|
|
|
|
Regulatory eSubmissions
Switching to Electric
eSubmissions are becoming a way of life, not only from a regulatory standpoint, but also in terms of efficiency. Darryl Clarke at Sciformix Corporation considers the new systems, processes and skillsets that come with the increased take-up of electronic Common Technical Document software.
|
|
|
CMO Quality Management
Level Best
Pushing for a rethink of the industry's use of quality management, Jim Grigg, Nikhil Patel, Joely Rigby and Penny Lisney from 3M Drug Delivery Systems make the case for a Lean Six Sigma approach to achieve product and service quality – driving operational excellence and continuous improvement.
|
|
|
|
|
Digital Signing
Access Denied
Those who fail to adapt to the digitalisation of the modern age do so at their own peril, warns Thales e-Security's John Grimm. Resistance to change will leave pharma and healthcare organisations sidelined, and unable to exploit the advantages to be seized through automating formerly manual processes.
|
|
|
Cyber Security
Digital Warfare
Neil Oliver of Accutronics states the case for protecting hardware against the worrying threats cyber criminals pose to medical and pharmaceutical systems. Encoding efforts to ensure equipment is safe and secure is now a vital first line of defence against impending healthcare hacks.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Turkish Cargo expands the ‘Pharma Corridor’ in its wide flight network.
Turkish Cargo, the fastest growing global air cargo brand thanks to its wide flight network, keeps bringing health to the world by carrying pharmaceuticals between destinations certified by the global aviation authorities.
The successful brand has created a pharma corridor between over 400 stations by carrying pharmaceuticals in important and certified destinations such as Mumbai, Brussels, Istanbul, Singapore, Dubai, Basel, London, and Amsterdam.
More info >> |
|
 |
White Papers |
 |
|
Industrial Security in the Pharmaceutical Sector
COPA-DATA
As an attractive target for cyber attacks, pharmaceutical companies need to understand cyber security, assess weak points and implement the appropriate security measures. This white paper describes some of the most effective industrial security tools pharmaceutical companies have at their disposal in the era of Industry 4.0.
More info >> |
|
 |
Industry Events |
 |
SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)
11-13 May 2020, Copthorne Tara Hotel, London, UK
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >> |
|
|
